Neurorehabilitation Devices Global Strategic Business Report 2023 - ResearchAndMarkets.com
05 Dec 2023
DUBLIN--(BUSINESS WIRE)--The "Neurorehabilitation Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
'Neurorehabilitation Devices - Global Strategic Business Report'
Global Neurorehabilitation Devices Market to Reach $4.5 Billion by 2030
The global market for Neurorehabilitation Devices estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$4.5 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2022-2030. Neurorobotic Systems, one of the segments analyzed in the report, is projected to record 18.6% CAGR and reach US$2 Billion by the end of the analysis period. Growth in the Brain Computer Interface segment is estimated at 12.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $494.3 Million, While China is Forecast to Grow at 21.2% CAGR
The Neurorehabilitation Devices market in the U.S. is estimated at US$494.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$628.2 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 16% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.
What`s New?
Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
Report Attribute
Details
No. of Pages
504
Forecast Period
2022 - 2030
Estimated Market Value (USD) in 2022
$1.4 Billion
Forecasted Market Value (USD) by 2030
$4.5 Billion
Compound Annual Growth Rate
15.7%
Regions Covered
Global
MARKET OVERVIEW
Neurological Disorders and Disability - A Prelude
Role of Neurorehabilitation in Enhancing Life Quality and Physical Function
An Insight into Neurorehabilitation Devices
Global Economic Update
World Shifts to an Endemic COVID-19 Strategy with Focus on Multilateral Approach to Managing Future Pandemics
War, Inflation & High Cost of Living Crisis Supersede COVID-19 as Major Downside Risks for the Global Economy in 2022 & Beyond
World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023
Neurorehabilitation Devices Market Adversely Impacted by COVID-19
Competitive Landscape
Neurorehabilitation Devices - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Global Market Prospects and Outlook
Global Neurorehabilitation Devices Market Radiates Signs of Vim & Vigor
Neurorehabilitation Remains Dynamic Domain with Progressive Advancements
Neuro-Robotic Devices: Thriving Segment of Neurorehabilitation Devices Market
Opportunity: Rising Uptake of Robotic Devices
Stroke Leads the End-uses of Neurorehabilitation Devices
North America Claims Authoritative Stake in Neurorehabilitation Devices Market
Immense Burden of Neurological Conditions in US Paves Way for Neurorehabilitation Devices
Asia-Pacific to Offer Lucrative Opportunities
Technological Advancements Drive Market Growth
Neurorehabilitation Becomes a Hotbed for VR & Robotic Technologies
Market Restraints
Recent Market Activity
MARKET TRENDS & DRIVERS
Rising Incidence of Neurological Conditions Drive Market Growth
Annual Incidence of Adult-Onset Neurologic Disorders in the US
Epilepsy Incidence Worldwide by Type: Percentage Breakdown for Idiopathic and Symptomatic Epilepsy by Type (2022))
Symptomatic Epilepsy Incidence: Percentage of Incidence by Type for 2022
Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Adoption of Neurorobotic Systems
Exoskeleton Robots Add Sophistication in Neurorehabilitation
The Imminent Rise of Exosuits
Innovative Exosuits Wearable Robots Promise Accelerated Recovery of Stroke Patients
Robotic Exoskeletons as Game-Changing Development for Neurorehabilitation
AI Augments Prosthetic Technology
Researchers Develop Neurorobotic Prosthetic Arm to Restore Natural Brain Behaviors
Select Robotic Devices
Robot-assisted Therapy Vs Other Therapies
Limitations
Technological Developments
New Generation Robotic Neurorehabilitation Devices Powered by Non-invasive Brain Machine Interfaces
Brain Stimulators Seek to Widen their Role in Neurorehabilitation
Global Alzheimer's Prevalence by Age Group: 2020
Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
Global DBS Market by Leading Player (2022): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
Select Available Deep Brain Stimulation Devices Available in the Market
Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
Innovative Multi-Electrodes with Potential to Improve Spinal Cord Stimulation
Non-Invasive Brain Stimulation
Innovative Multi-electrode Stimulation Paves Way for Recovery from Spinal Cord Injuries
Neurorehabilitation Therapy in Epilepsy Care
Neurorehabilitation Wearable Devices Market Set to Deliver Stunning Performance
Novel Wristbands: A Primary Market Driver
Wearable Robotic Devices for Neurorehabilitation
Wearable Devices Set to Transform Traditional Approaches to Neurorehabilitation of Stroke Patients
Primary Wearable Sensors for Stroke Patients
Robotic Neurorehabilitation & Noninvasive Brain-Machine Interface to Aid Rehabilitation
Brain-Machine Interfaces
Key Applications of Virtual Reality for Neurological Rehabilitation
VR-Centric Gamification in Neurorehabilitation Improves Outcomes for Stroke Patients
Start-ups Leveraging VR for Gamification in Stroke Patient Rehabilitation
Technological Advancements in Neuroimaging Techniques Enhance Neurorehabilitation Outcome
Advancements in Robotics and Neuroscience Research Give Rise to Next-Generation Rehabilitation Techniques
IoT-Powered Rehabilitation Robotics
Integration Of Speech Recognition Algorithms
Emergence of Novel Multi-electrode Stimulation for Treatment of Spinal Cord Injuries
Startups Eye on Affordable Solutions to Spur Neurorehabilitation Uptake across Low- & Middle-Income Nations
Tailored and Affordable Neurorehab Technologies
Smartphone Technology to Support Neurorehabilitation
AR's role in Neurorehabilitation Recovery and Assessment
AR Augments the Existing Neurorehabilitation Programs
Electrotherapy Emerges a Mega Trend in Neuromuscular Rehabilitation Space
Why Metaverse Technology is Soaking Limelight for Holistic Neurological Rehabilitation
Neurological Disorders that Could Benefit from Metaverse
Moving from Mono-Therapeutic to Holistic Neurorehabilitation with Metaverse
FOCUS ON SELECT PLAYERS (Total 105 Featured)
Eodyne
Instead Technologies Ltd.
Neofect
Neuro Rehab VR
For more information about this report visit https://www.researchandmarkets.com/r/14vjw0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.